Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities

NCT06794996 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Proteinuric Kidney Disease

Interventions

DRUG: Inaxaplin

Sponsor

Vertex Pharmaceuticals Incorporated